[Federal Register Volume 86, Number 83 (Monday, May 3, 2021)]
[Notices]
[Pages 23372-23373]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-09006]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Council for the Elimination of Tuberculosis (ACET)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting of the Advisory Council for the 
Elimination of Tuberculosis Meeting (ACET). This meeting is open to the 
public and limited to 1,000 audio and web conference lines. Time will 
be available for public comment.

DATES: The meeting will be held on June 15, 2021, from 10:00 a.m. to 
3:45 p.m., EDT, and June 16, 2021, from 10:00 a.m. to 12:00 p.m., EDT.
    The public is welcome to submit written comments in advance of the 
meeting. Comments should be submitted in writing by email to the 
contact person listed below. In the subject line, please note ATTN: 
Staci for ACET Public Comment. The public comment should include your 
name, affiliation, and email address.
    Comments must be received on or before June 14, 2021.

ADDRESSES: The web conference access is: https://cdc.zoomgov.com/j/1612817912?pwd=dFRoNDJvWjh3Q0NtTDFjWnJya2xJZz09

Passcode: 8ed4G7=S
Webinar ID: 161 281 7912

    The teleconference access is noted as follows:
    Telephone number: 1-669-254-5252; and the passcode is 53466615.

FOR FURTHER INFORMATION CONTACT: Staci Morris, Committee Management 
Specialist, CDC, 1600 Clifton Road NE, Mailstop US8-6, Atlanta, Georgia 
30329-4027; Telephone: (404) 718-7479; Email: [email protected]. 
(In the subject line, please note ATTN: Staci for ACET Public Comment.)

SUPPLEMENTARY INFORMATION:
    Purpose: This Council advises and makes recommendations to the

[[Page 23373]]

Secretary of Health and Human Services, the Assistant Secretary for 
Health, and the Director, CDC, regarding the elimination of 
tuberculosis. Specifically, the Council makes recommendations regarding 
policies, strategies, objectives, and priorities; addresses the 
development and application of new technologies; and reviews the extent 
to which progress has been made toward eliminating tuberculosis.
    Matters to be Considered: The agenda will include discussions on 
(1) 2020 TB provisional surveillance data; (2) Tuberculosis Trials 
Consortium Update; (3) COVID impact on TB programs; (4) Perceptions of 
non-U.S.-born persons on the link between country of birth and TB risk; 
(5) Using Big Data to Understand Latent Tuberculosis Care in the United 
States; and (6) Bacillus Calmette-Guerin Vaccine Guidance Development. 
Agenda items are subject to change as priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-09006 Filed 4-30-21; 8:45 am]
BILLING CODE 4163-18-P